Methotrexate reduces circulating Th17 cells and impairs plasmablast and memory B cell expansions following pneumococcal conjugate immunization in RA patients
Abstract Methotrexate (MTX) impairs antibody response after pneumococcal vaccination. We aimed to investigate differences in phenotypes of circulating B and T cells after pneumococcal conjugate vaccine (PCV) in rheumatoid arthritis (RA) patients on MTX (MTX group), RA without disease-modifying drugs...
Guardado en:
Autores principales: | Per Nived, Åsa Pettersson, Göran Jönsson, Anders A. Bengtsson, Bo Settergren, Lillemor Skattum, Åsa Johansson, Meliha C. Kapetanovic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a09d28726ee74ffea54757d1103c15b3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Plasmablastic lymphoma: current perspectives
por: Lopez A, et al.
Publicado: (2018) -
Maturation trajectories and transcriptional landscape of plasmablasts and autoreactive B cells in COVID-19
por: Christoph Schultheiß, et al.
Publicado: (2021) -
Pneumococcal conjugate vaccines: New hope for infancy
por: Black,Steven B., et al.
Publicado: (2001) -
Serotype distribution in non-bacteremic pneumococcal pneumonia: association with disease severity and implications for pneumococcal conjugate vaccines.
por: Thomas Benfield, et al.
Publicado: (2013) -
Use of biotin targeted methotrexate–human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy
por: Taheri A, et al.
Publicado: (2011)